Time in therapeutic range among warfarin users in Turkey: Are there enough data to set definitive criteria for reimbursement?

Turk Kardiyol Dern Ars. 2021 Jun;49(4):254-256. doi: 10.5543/tkda.2021.94055.
No abstract available

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Administration, Oral
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications*
  • Female
  • Humans
  • Insurance, Health, Reimbursement*
  • International Normalized Ratio*
  • Male
  • Middle Aged
  • Stroke / prevention & control*
  • Time Factors
  • Turkey
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Warfarin